Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
Coverage
![Freeport-McMoRan (FCX) Declares $0.08 Dividend](https://i0.wp.com/www.nasdaqpicks.com/wp-content/uploads/2023/03/Freeport-McMoRan-FCX-Declares-008-Dividend-400x400.jpg)
Mizuho Initiates Coverage of Vigil Neuroscience (VIGL) with Buy Recommendation
- By nasdaqpicks.com
- . 31 March 2023
On March 31, 2023, Mizuho initiated coverage of Vigil Neuroscience with a Buy recommendation. Analyst Price Forecast Suggests 109.31% Upside As of March 30, 2023,
![Freeport-McMoRan (FCX) Declares $0.08 Dividend](https://i0.wp.com/www.nasdaqpicks.com/wp-content/uploads/2023/03/Freeport-McMoRan-FCX-Declares-008-Dividend-400x400.jpg)
Canaccord Genuity Initiates Coverage of Driven Brands Holdings (DRVN) with Buy Recommendation
- By nasdaqpicks.com
- . 31 March 2023
On March 30, 2023, Canaccord Genuity initiated coverage of Driven Brands Holdings with a Buy recommendation. Analyst Price Forecast Suggests 32.33% Upside As of March
![Freeport-McMoRan (FCX) Declares $0.08 Dividend](https://i0.wp.com/www.nasdaqpicks.com/wp-content/uploads/2023/03/Freeport-McMoRan-FCX-Declares-008-Dividend-400x400.jpg)
Canaccord Genuity Initiates Coverage of Lifetime Brands (LCUT) with Buy Recommendation
- By nasdaqpicks.com
- . 31 March 2023
On March 30, 2023, Canaccord Genuity initiated coverage of Lifetime Brands with a Buy recommendation. Analyst Price Forecast Suggests 111.78% Upside As of March 30,
![Freeport-McMoRan (FCX) Declares $0.08 Dividend](https://i0.wp.com/www.nasdaqpicks.com/wp-content/uploads/2023/03/Freeport-McMoRan-FCX-Declares-008-Dividend-400x400.jpg)
Stifel Initiates Coverage of Immunovant (IMVT) with Buy Recommendation
- By nasdaqpicks.com
- . 31 March 2023
On March 30, 2023, Stifel initiated coverage of Immunovant with a Buy recommendation. Analyst Price Forecast Suggests 56.92% Upside As of March 30, 2023, the
![Freeport-McMoRan (FCX) Declares $0.08 Dividend](https://i0.wp.com/www.nasdaqpicks.com/wp-content/uploads/2023/03/Freeport-McMoRan-FCX-Declares-008-Dividend-400x400.jpg)
Canaccord Genuity Initiates Coverage of Spectrum Brands Holdings (SPB) with Buy Recommendation
- By nasdaqpicks.com
- . 31 March 2023
On March 30, 2023, Canaccord Genuity initiated coverage of Spectrum Brands Holdings with a Buy recommendation. Analyst Price Forecast Suggests 27.12% Upside As of March
![Freeport-McMoRan (FCX) Declares $0.08 Dividend](https://i0.wp.com/www.nasdaqpicks.com/wp-content/uploads/2023/03/Freeport-McMoRan-FCX-Declares-008-Dividend-400x400.jpg)
TD Cowen Initiates Coverage of Waste Management (WM) with Outperform Recommendation
- By nasdaqpicks.com
- . 31 March 2023
On March 30, 2023, TD Cowen initiated coverage of Waste Management with a Outperform recommendation. Analyst Price Forecast Suggests 9.32% Upside As of March 30,
![Texas judge blocks Obamacare coverage mandate for PrEP, cancer screening By Reuters](https://i0.wp.com/www.nasdaqpicks.com/wp-content/uploads/2023/03/Texas-judge-blocks-Obamacare-coverage-mandate-for-PrEP-cancer-screening-400x400.jpg)
Texas judge blocks Obamacare coverage mandate for PrEP, cancer screening By Reuters
- By nasdaqpicks.com
- . 30 March 2023
© Reuters. FILE PHOTO: A sign on an insurance store advertises Obamacare in San Ysidro, San Diego, California, U.S., October 26, 2017. REUTERS/Mike Blake By
![Freeport-McMoRan (FCX) Declares $0.08 Dividend](https://i0.wp.com/www.nasdaqpicks.com/wp-content/uploads/2023/03/Freeport-McMoRan-FCX-Declares-008-Dividend-400x400.jpg)
HC Wainwright & Co. Initiates Coverage of Legend Biotech (LEGN) with Buy Recommendation
- By nasdaqpicks.com
- . 30 March 2023
On March 29, 2023, HC Wainwright & Co. initiated coverage of Legend Biotech with a Buy recommendation. Analyst Price Forecast Suggests 51.50% Upside As of
![Freeport-McMoRan (FCX) Declares $0.08 Dividend](https://i0.wp.com/www.nasdaqpicks.com/wp-content/uploads/2023/03/Freeport-McMoRan-FCX-Declares-008-Dividend-400x400.jpg)
UBS Initiates Coverage of Edwards Lifesciences (EW) with Neutral Recommendation
- By nasdaqpicks.com
- . 30 March 2023
On March 29, 2023, UBS initiated coverage of Edwards Lifesciences with a Neutral recommendation. Analyst Price Forecast Suggests 9.47% Upside As of March 29, 2023,
![Freeport-McMoRan (FCX) Declares $0.08 Dividend](https://i0.wp.com/www.nasdaqpicks.com/wp-content/uploads/2023/03/Freeport-McMoRan-FCX-Declares-008-Dividend-400x400.jpg)
UBS Initiates Coverage of DexCom (DXCM) with Buy Recommendation
- By nasdaqpicks.com
- . 30 March 2023
On March 29, 2023, UBS initiated coverage of DexCom with a Buy recommendation. Analyst Price Forecast Suggests 18.96% Upside As of March 28, 2023, the